Blue Chip Biotech Companies on Target for a Record Year
Despite the fact that biotech companies developing biopharmaceuticals had a challenging month in October, with the 258 publicly listed companies tracked by the BioWorld Stock Report recording an average 7 percent drop in their share values, there is certainly no indication that the sector’s surge has stalled. In fact, despite predictions that biotech’s momentum has finally run out of steam, with less than two months to go until the end of the year biotech companies both large and small are still on target to post record-setting performances, a feat that has not been seen since 2000.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter